Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
about
Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary diseaseSputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPDB-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.β-Blockers are associated with a reduction in COPD exacerbations.Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?Lung ultrasound B-lines in exacerbations of chronic obstructive pulmonary disease.Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases.Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.This patient is not breathing properly: is this COPD, heart failure, or neither?Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPDBeta-blocker under-use in COPD patients.Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis.The role of beta-blockers in the management of chronic obstructive pulmonary disease.An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.Chronic obstructive pulmonary disease and β-blocker treatment in Asian patients with heart failure.The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.What can we learn from pulmonary function testing in heart failure?Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study
P2860
Q33552609-DE00BF2D-9B2E-4A55-A672-2B14A720F335Q33814586-A7046F9D-039E-46DC-8585-0BFC19EA724EQ35168749-4E14F0A5-0043-4135-A1A4-68C2EE1B0CA9Q35683454-14281572-EBAF-42C3-B59B-4FF3D5DADA25Q36245755-93DA5AFC-E9A8-4BDE-B0CE-5D378D211F1DQ37471531-A9239C42-EF1B-466D-9F09-EC61244F3AD9Q37499919-315992CA-5C29-4F84-A973-FB391BF8D37FQ38345525-69A67C8F-66A9-4A30-BA60-21C018888BAFQ38613058-41EA7C56-77AA-4D2F-AE5B-4EB67F4EDFE9Q38750625-FE0749A9-4A4C-440C-A264-33E62C69766DQ38871993-E0E4033A-3148-4376-A2CF-26F000EC01D5Q38944856-B324493D-D589-4AA8-9D14-B39625D49B0EQ39232408-A1C8C33B-978C-4648-860D-8D806AB2C2A7Q40771974-9CF187B4-4FC6-46F9-BC6D-771DDCA80043Q42688095-BD3EE09C-03A6-477D-BA0F-910F72A28F88Q47123558-603B068B-8D69-4081-A34C-019382CD0486Q47127548-E42DC39B-94F2-4774-9217-1E179D50D99FQ47676572-85569747-2A36-4107-AEC9-187857B731A7Q47728819-FBDCE7A9-8719-41A0-A681-8231C5248D82Q47746323-00B050AC-9FE3-4AB3-B678-BF9039899652Q47792766-161961EF-CA29-4D85-AD0A-4B7AD7910643Q48014750-CA8FFEB3-CE5A-45DA-B0CF-7189681922E2Q50064555-2C47B2D1-F41D-4A59-927B-07B53F0A4739Q50145168-D8BF4A8A-F9EE-4222-8A37-2BBDFD6D3A81Q53112864-16EA9E34-8BD9-4959-8FD5-6B1C1300FAE7Q59136323-833F2F39-857B-485E-8CD6-AAD877EF582A
P2860
Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Beta-blockers reduced the risk ...... ysis of observational studies.
@ast
Beta-blockers reduced the risk ...... ysis of observational studies.
@en
Beta-blockers reduced the risk ...... ysis of observational studies.
@nl
type
label
Beta-blockers reduced the risk ...... ysis of observational studies.
@ast
Beta-blockers reduced the risk ...... ysis of observational studies.
@en
Beta-blockers reduced the risk ...... ysis of observational studies.
@nl
prefLabel
Beta-blockers reduced the risk ...... ysis of observational studies.
@ast
Beta-blockers reduced the risk ...... ysis of observational studies.
@en
Beta-blockers reduced the risk ...... ysis of observational studies.
@nl
P2093
P2860
P921
P1433
P1476
Beta-blockers reduced the risk ...... ysis of observational studies.
@en
P2093
Qingxia Du
Yongchang Sun
P2860
P304
P356
10.1371/JOURNAL.PONE.0113048
P407
P577
2014-11-26T00:00:00Z